论文部分内容阅读
A number of drugs only give rise to limited clinical response when causing remarkable toxicities due to wide distribution and off-target effects.One possible approach to overcome such limitations is the use of nanobiotechnologyvia delivering the drugs to the diseased site with a high selectivity and controlled distribution.I am interested in the design of new drug delivery systems for anticancer drugs and other therapeutics.